Volume 20, Issue 8 (November 2022)                   Nursing and Midwifery Journal 2022, 20(8): 639-644 | Back to browse issues page


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Mousazadeh Y, Salmani R, Bagherbandi S. REPORT OF A CASE OF SUCCESSFUL PREGNANCY AND DELIVERY FOLLOWING DRUG REACTION AND STEVENS-JOHNSON SYNDROME. Nursing and Midwifery Journal 2022; 20 (8) :639-644
URL: http://unmf.umsu.ac.ir/article-1-4690-en.html
1- Department of Public Health, Khalkhal University of Medical Sciences, Khalkhal, Iran
2- Department of Midwifery, Khalkhal University of Medical Sciences, Khalkhal, Iran (Corresponding Author) , salmany.ro@gmail.com
3- Khalkhal University of Medical Sciences, Khalkhal, Iran
Abstract:   (549 Views)
Background & Aims: Stevens Johnson syndrome (SJS) is a severe hypersensitive reaction and a life-threatening, immunologically mediated and usually drug-induced disease. Sulfonamides, allopurinol, and cold medicines are some of these allergen drugs. pregnant women comprise a subset of individuals at risk for SJS development. The aim of the article was to report a success pregnancy and delivery in a woman after 5 years of SJS diagnosis.
Case Report: This case report study was conducted at Imam Khomeini Hospital in Khalkhal, Iran. In this study, we discussed on the history of pregnancy and delivery in a woman 5 years following SJS diagnosis with vaginal stenosis resulting from Azithromycin and Naproxen treatment for cold. This study showed that there is a possibility of successful pregnancy and delivery in the people with SJS and long-term complications caused by it.
Conclusion: Health care providers must be careful concerning drug reactions, especially the occurrence of SJS, which is a potentially harmful and fatal condition.
Full-Text [PDF 508 kb]   (191 Downloads)    
Type of Study: Research | Subject: مامایی

References
1. Jongkhajornpong P, Lekhanont K, Pisuchpen P, Chantaren P, Puangsricharern V, Prabhasawat P, et al. Association between HLA-B* 44: 03-HLA-C* 07: 01 haplotype and cold medicine-related Stevens-Johnson syndrome with severe ocular complications in Thailand. Br J Ophthalmol 2018;102(9):1303-7. [DOI:10.1136/bjophthalmol-2017-311823] [PMID]
2. Jain R, Sharma N, Basu S, Iyer G, Ueta M, Sotozono C, et al. Stevens-Johnson syndrome: The role of an ophthalmologist. Surv Ophthalmol 2016;61(4):369-99. [DOI:10.1016/j.survophthal.2016.01.004] [PMID]
3. Kittipibul T, Puangsricharern V & Chatsuwan T. Comparison of the ocular microbiome between chronic Stevens-Johnson syndrome patients and healthy subjects. Sci Rep 2020;10(1):1-9. [DOI:10.1038/s41598-020-60794-w] [PMID] [PMCID]
4. Yap FBB, Wahiduzzaman M & Pubalan M. Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in Sarawak: A four years review. Egypt Dermatol Online J 2008;4(1):1-13.
5. Sekula P, Dunant A, Mockenhaupt M, Naldi L, Bouwes Bavinck JN, Halevy S, et al. Comprehensive survival analysis of a cohort of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis. J Invest Dermatol 2013;133(5):1197-204. [DOI:10.1038/jid.2012.510] [PMID]
6. Frisch PO, Ruiz-Maldonado R. Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrosis. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA & Katz SI, editors. Fitzpatrick's Dermatology in General Medicine. 6nd ed. New York: McGraw-Hill; 2003.p.543-57. [Google Scholar]
7. White K, Abe R, Ardern-Jones M, Beachkofsky T, Bouchard C, Carleton B, et al. SJS/TEN 2017: Building Multidisciplinary Networks to Drive Science and Translation. J Allergy Clin Immunol 2018; 6(1):38-69. [DOI:10.1016/j.jaip.2017.11.023] [PMID] [PMCID]
8. Brett SA, Phillips D, Lynn AW. Intravenous immunoglobulin therapy for Stevens-Johnson Syndrome. South Med J 2001;94(3):342-3. https://doi.org/10.1097/00007611-200194030-00014 [DOI:10.1097/00007611-200103000-00014] [PMID]
9. Saeed H, Mantagos IS, Chodosh J. Complications of Stevens-Johnson syndrome beyond the eye and skin. Burns 2016; 42(1):20-7. [DOI:10.1016/j.burns.2015.03.012] [PMID]
10. El Daief SG, Das S, Ekekwe G, Nwosu EC. A successful pregnancy outcome after Stevens-Johnson syndrome. J Obs Gynaecol 2014;34(5):445-6. [DOI:10.3109/01443615.2014.914897] [PMID]
11. Struck MF, Illert T, Liss Y, Bosbach ID, Reichelt B & Steen M. Toxic epidermal necrolysis in pregnancy: case report and review of the literature. J Burn Care Res 2010;31(5):816-21. [DOI:10.1097/BCR.0b013e3181eed441] [PMID]
12. Gupta LK, Martin AM, Agarwal N, D'Souza P, Das S, Kumar R, Pande S, Das NK, Kumaresan M, Kumar P, et al. Guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis: An Indian perspective. Indian J Dermatol Venereol Leprol 2016;82(6):603-25. [DOI:10.4103/0378-6323.191134] [PMID]
13. Niemeijer IC, van Praag MC & van Gemund N. Relevance and consequences of erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in gynecology. Arch Gynecol Obstet 2009;280(5):851-4. [DOI:10.1007/s00404-009-1008-1] [PMID]
14. Dube N, Adewusi E & Summers R. Risk of nevirapine-associated Stevens-Johnson syndrome among HIV-infected pregnant women: The Medunsa National Pharmacovigilance Centre, 2007-2012. S Afr Med J 2013;103(5):322-4. [DOI:10.7196/SAMJ.6077] [PMID]
15. Finkelstein Y, Soon G, Acuna P, George M, Pope E, Ito S, et al. Recurrence and Outcomes of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Children. Pediatrics 2011;128(4):723-8. [DOI:10.1542/peds.2010-3322] [PMID]
16. Pirmohamed M, Lin K, Chadwick D, Park BK. TNF alpha promoter region gene polymorphisms in carbamazepine-hypersensitive patients. Neurology 2001;56(7):890-6. [DOI:10.1212/WNL.56.7.890] [PMID]
17. Hur J, Zhao C, Bai JP. Systems pharmacological analysis of drugs inducing stevens-johnson syndrome and toxic epidermal necrolysis. Chem Res Toxicol 2015;28(5):927-34. doi: 10.1021/tx5005248. Epub 2015 Apr 3. PMID: 25811541. [DOI:10.1021/tx5005248] [PMID]
18. Xu L, Zhu Y, Yu J, Deng M, Zhu X. Nursing care of a boy seriously infected with Steven-Johnson syndrome after treatment with azithromycin: A case report and literature review. Medicine 2018;97(1):e9112. doi: 10.1097/MD.0000000000009112. PMID: 29505509; PMCID: PMC5943129. [DOI:10.1097/MD.0000000000009112] [PMID] [PMCID]
19. Nappe TM, Goren-Garcia SL, Jacoby JL. Stevens - Johns on syndrome. after treatment with azithromycin: an uncommon culprit. Am J Emerg Med 2016;34(3):676-e1 [DOI:10.1016/j.ajem.2015.06.039] [PMID]
20. Yadav R, Srivastava A, Pawar P, Mendiratta V, Tayal P. A rare case of toxic epidermal necrolysis in pregnancy. Int J Reprod Contracept Obstet Gynecol 2020;9(2):846. [DOI:10.18203/2320-1770.ijrcog20200391]
21. de Jesus LE, Dekermacher S, Manhaes CR, Faria LM, Barros ML. Acquired labial sinechiae and hydrocolpos secondary to Stevens-Johnson syndrome. Urology 2012t;80(4):919-21. [DOI:10.1016/j.urology.2012.06.051] [PMID]
22. Kratzert K, Marks F, Antoine C, Brescia RJ, Parodneck L, Young BK. Pregnancy post-Stevens-Johnson syndrome: case report and review of the literature. Obstet Gynecol 1988;72(3 Pt 2):447-50. [Google Scholar]
23. Finkelstein Y, Soon G, Acuna P, George M, Pope E, Ito S, et al. Recurrence and Outcomes of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Children. Pediatrics 2011;128(4):723-8. [DOI:10.1542/peds.2010-3322] [PMID]
24. Di Marco N, Schaink JM, Cranswick NE, Sawyer SM. Stevens-Johnson syndrome: Old and new opportunities for prevention. J Paediatrics Child Health 2015;51(9):924-6. [DOI:10.1111/jpc.12883] [PMID]
25. Wanscher B, Thormann J. Permanent Anonychia After Stevens-Johnson Syndrome. Arch Dermatol 1977;113(7):970. doi:10.1001/archderm.1977.01640070104018 [DOI:10.1001/archderm.1977.01640070104018] [PMID]
26. Graham-Brown R AC, Cochrane G W, Swinhoe JR, Sarkany I & Epsztejn LJ. Vaginal Stenosis duf to bullous erythema multiforme (Stevens-Johnson Syndrome) case report. BJOG: Int J Obstet Gynaecol 1981;88(11):1156-7. [DOI:10.1111/j.1471-0528.1981.tb01772.x] [PMID]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2023 CC BY-NC 4.0 | Nursing And Midwifery Journal

Designed & Developed by : Yektaweb